Trial Profile

A Randomized Trial Testing Early Vs Late Onset of EPO Alfa Treatment in Lower Risk MDS with Non RBC Transfusion Dependent Anemia and Without Del 5q

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 16 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Epoetin alfa (Primary)
Indications Anaemia
Focus Therapeutic Use
Acronyms EPO-PRETAR

Most Recent Events

11 Mar 2025 Planned End Date changed from 16 May 2024 to 1 Oct 2028.
11 Mar 2025 Status changed from recruiting to active, no longer recruiting.
06 Nov 2020 Planned End Date changed from 1 Oct 2021 to 16 May 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com